医学
心脏病学
主动脉瓣
内科学
主动脉瓣关闭不全
外科
作者
Do‐Yoon Kang,Jung‐Min Ahn,Juyong Brian Kim,Alan C. Yeung,Takeshi Nishi,William F. Fearon,Eric Cantey,James D. Flaherty,Charles J. Davidson,S. Chris Malaisrie,Seo Young Park,Sung‐Cheol Yun,Euihong Ko,Hanbit Park,Seung‐Ah Lee,Dae‐Hee Kim,Ho Jin Kim,Joon Bum Kim,Suk Jung Choo,Duk‐Woo Park
出处
期刊:Heart
[BMJ]
日期:2022-02-02
卷期号:108 (19): 1562-1570
被引量:2
标识
DOI:10.1136/heartjnl-2021-320364
摘要
Little information exists about inter-racial differences in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). We investigated whether differences in baseline characteristics between Asian and non-Asian population may contribute to disparities in clinical outcomes after TAVI. We performed a registry-based, multinational cohort study of patients with severe AS who underwent TAVI at two centres in the USA and one centre in South Korea. The primary outcome was a composite of death, stroke or rehospitalisation at 1 year. Of 1412 patients, 581 patients were Asian and 831 were non-Asian (87.5% white, 1.7% black, 6.1% Hispanic or 4.7% others). There were substantial differences in baseline characteristics between two racial groups. The primary composite outcome was significantly lower in the Asian group than in the non-Asian group (26.0% vs 35.0%; HR 0.73; 95% CI 0.59 to 0.89; p=0.003). However, after adjustment of baseline covariates, the risk of primary composite outcome was not significantly different (HR 0.79; 95% CI 0.60 to 1.03; p=0.08). The all-cause mortality at 1 year was significantly lower in the Asian group than the non-Asian group (7.4% vs 12.5%; HR 0.60; 95% CI 0.41 to 0.88; p=0.009). After multivariable adjustment, the risk of all-cause mortality was also similar (HR 1.17; 95% CI 0.73 to 1.88; p=0.52). There were significant differences in baseline and procedural factors among Asian and non-Asian patients who underwent TAVI. Observed inter-racial differences in clinical outcomes were largely explained by baseline differences in clinical, anatomical and procedural factors. NCT03826264 (https://wwwclinicaltrialsgov).
科研通智能强力驱动
Strongly Powered by AbleSci AI